ANTHONY SHARP: Open Payments
NPI 1376873281 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,202 in 61 payments from 13 companies in 2025. Trend: 2023 $1,755 · 2024 $2,537 · 2025 $2,202
Food & beverage: $2,202
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 28 | $1,066 |
| GENZYME CORPORATION | 3 | $240 |
| Novartis Pharmaceuticals Corporation | 6 | $204 |
| TG Therapeutics, Inc. | 3 | $175 |
| Biogen, Inc. | 4 | $98 |
| Alexion Pharmaceuticals, Inc. | 1 | $82 |
| ABBVIE INC. | 4 | $74 |
| Celgene Corporation | 4 | $67 |
| Amgen Inc. | 3 | $66 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
Products named: KESIMPTA, BRIUMVI, TYSABRI, ZEPOSIA, UPLIZNA, QULIPTA, AJOVY, UBRELVY.
Industry payments across OK — which companies pay providers there.
